Divergent Response to Growth Hormone in Two Siblings With Cartilage-Hair Hypoplasia: A Case Report

Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive skeletal dysplasia caused by biallelic variants in the RMRP gene. It combines disproportionate short stature with variable immunological, hematological, and gastrointestinal involvement. Evidence on treatment with recombinant human growth hormone (rhGH) in this condition is limited and inconsistent. We describe the case of two siblings with genetically confirmed CHH who presented with severe short stature and subnormal growth hormone stimulation tests and who were treated with rhGH for different periods. The boy showed a clear increase in growth velocity and height standard deviation score, partly maintained after treatment was stopped, whereas the girl showed only a minimal and transient response. Both siblings later developed obesity-related metabolic changes, including insulin resistance, and had T-cell lymphopenia, which was clinically more severe in the girl. This report illustrates that siblings with the same genotype can respond very differently to rhGH, and it highlights the need for early endocrine, metabolic, and immunological surveillance in children with CHH.

Authors

Publication Details

Journal
Cureus
Published
2026-11-21
DOI
https://doi.org/10.7759/cureus.120056
Primary Topic
Growth Hormone and Insulin-like Growth Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Divergent Response to Growth Hormone in Two Siblings With Cartilage-Hair Hypoplasia: A Case Report

Maria Miguel Gomes, Lara Torres, Mariana Portela, Ana Antunes et al.
Cureus
Growth Hormone and Insulin-like Growth Factors
article

Divergent Response to Growth Hormone in Two Siblings With Cartilage-Hair Hypoplasia: A Case Report

Maria Miguel Gomes, Lara Torres, Mariana Portela, Ana Antunes, Sofia Martins
article en

Abstract

Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive skeletal dysplasia caused by biallelic variants in the RMRP gene. It combines disproportionate short stature with variable immunological, hematological, and gastrointestinal involvement. Evidence on treatment with recombinant human growth hormone (rhGH) in this condition is limited and inconsistent. We describe the case of two siblings with genetically confirmed CHH who presented with severe short stature and subnormal growth hormone stimulation tests and who were treated with rhGH for different periods. The boy showed a clear increase in growth velocity and height standard deviation score, partly maintained after treatment was stopped, whereas the girl showed only a minimal and transient response. Both siblings later developed obesity-related metabolic changes, including insulin resistance, and had T-cell lymphopenia, which was clinically more severe in the girl. This report illustrates that siblings with the same genotype can respond very differently to rhGH, and it highlights the need for early endocrine, metabolic, and immunological surveillance in children with CHH.

Cureus
Growth Hormone and Insulin-like Growth Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Divergent Response to Growth Hormone in Two Siblings With Cartilage-Hair Hypoplasia: A Case Report — Maria Miguel Gomes, Lara Torres, et al. · Cureus (2026) | TGRS Research Map | TGRS